AAV9 gene replacement therapy in two mutant mouse models of CMT1X demyelinating neuropathy

被引：0
|
作者：
Kagiava, A. [1 ,2 ]
Karaiskos, C. [1 ,2 ]
Lapathitis, G. [1 ,2 ]
Sargiannidou, I. [1 ,2 ]
Bosch, A. [3 ]
Kleopa, K. A. [1 ,2 ,4 ,5 ]
机构：
[1] Cyprus Inst Neurol & Genet, Neurosci Dept, Engomi, Cyprus
[2] Cyprus Sch Mol Med, Engomi, Cyprus
[3] Univ Autonoma Barcelona, Inst Neurosci, Dept Biochem & Mol Biol, Barcelona, Spain
[4] Cyprus Inst Neurol & Genet, Ctr Neuromuscular Disorders, Engomi, Cyprus
[5] Cyprus Sch Mol Med, Engomi, Cyprus
来源：
HUMAN GENE THERAPY | 2021年 / 32卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P305
引用
收藏
页码：A121 / A122
页数：2
相关论文
共 50 条
  • [1] AAV9 gene replacement therapy in two mutant mouse models of CMT1X demyelinating neuropathy
    Kagiava, Alexia
    Karaiskos, Christos
    Lapathitis, George
    Sargiannidou, Irene
    Bosch, Assumpcio
    Kleopa, Kleopas
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 327 - 327
  • [2] Gene replacement therapy for CMT1X neuropathy
    Kagiava, Alexia
    Richter, Jan
    Tryfonos, Christina
    Karaiskos, Christos
    Sargiannidou, Irene
    Christodoulou, Christina
    Kleopa, Kleopas
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 332 - 332
  • [3] AAV9-MEDIATED POST-ONSET GENE REPLACEMENT THERAPY BENEFITS TRANSGENIC MODELS OF CMT1X NEUROPATHY
    Kagiava, Alexia
    Karaiskos, Christos
    Lapathitis, George
    Sargiannidou, Irene
    Bosch, Assumpcio
    Kleopa, Kleopas
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S63 - S63
  • [4] INTRATHECAL GENE THERAPY IN DIFFERENT MUTANT MOUSE MODELS OF CMT1X
    Kagiava, A.
    Karaiskos, C.
    Richter, J.
    Tryfonos, C.
    Lapathitis, G.
    Sargiannidou, I
    Christodoulou, C.
    Kleopa, K. A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 310 - 311
  • [5] Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy
    Kagiava, Alexia
    Karaiskos, Christos
    Lapathitis, George
    Heslegrave, Amanda
    Sargiannidou, Irene
    Zetterberg, Henrik
    Bosch, Assumpcio
    Kleopa, Kleopas A.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 377 - 393
  • [6] AXONAL DEGENERATION IN MOUSE MODELS OF CMT1X NEUROPATHY
    Sargiannidou, I
    Vavlitou, N.
    Markoullis, K.
    Kyriacou, K.
    Scherer, S. S.
    Kleopa, K. A.
    GLIA, 2009, 57 (13) : S118 - S118
  • [7] AAVrh10 Mediated Gene Replacement Therapy Targeted to Schwann Cells to Treat CMT1X Demyelinating Neuropathy
    Kagiava, Alexia
    Christou, Melina
    Sargiannidou, Irene
    Kleopa, Kleopas A.
    MOLECULAR THERAPY, 2023, 31 (04) : 340 - 340
  • [8] Intrathecal gene therapy in mouse models expressing CMT1X mutations
    Kagiava, A.
    Karaiskos, C.
    Richter, J.
    Tryfonos, C.
    Lapathitis, G.
    Sargiannidou, I.
    Christodoulou, C.
    Kleopa, K. A.
    HUMAN MOLECULAR GENETICS, 2018, 27 (08) : 1460 - 1473
  • [9] Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X
    Kagiava, A.
    Richter, J.
    Tryfonos, C.
    Karaiskos, C.
    Heslegrave, A. J.
    Sargiannidou, I
    Rossor, A. M.
    Zetterberg, H.
    Reilly, M. M.
    Christodoulou, C.
    Kleopa, K. A.
    HUMAN MOLECULAR GENETICS, 2019, 28 (21) : 3528 - 3542
  • [10] INTRATHECAL GENE THERAPY IN A NEUROPATHY MODEL EXPRESSING A CMT1X MUTATION
    Kagiava, A.
    Karaiskos, C.
    Richter, J.
    Sargiannidou, I
    Christodoulou, C.
    Kleopa, K. A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) : 268 - 268
12345